PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
2.60%
Revenue growth under 50% of ADI's 6.35%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
3.58%
Gross profit growth under 50% of ADI's 8.18%. Michael Burry would be concerned about a severe competitive disadvantage.
5.30%
EBIT growth below 50% of ADI's 19.75%. Michael Burry would suspect deeper competitive or cost structure issues.
5.43%
Operating income growth under 50% of ADI's 19.75%. Michael Burry would be concerned about deeper cost or sales issues.
6.10%
Net income growth under 50% of ADI's 14.87%. Michael Burry would suspect the firm is falling well behind a key competitor.
6.45%
EPS growth under 50% of ADI's 15.79%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
6.56%
Diluted EPS growth under 50% of ADI's 14.04%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.99%
Share reduction while ADI is at 0.45%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.94%
Reduced diluted shares while ADI is at 0.43%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.43%
Dividend growth under 50% of ADI's 8.03%. Michael Burry might suspect more pressing needs for cash or weaker earnings power.
34.65%
OCF growth under 50% of ADI's 103.99%. Michael Burry might suspect questionable revenue recognition or rising costs.
43.00%
FCF growth under 50% of ADI's 103.46%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
57.57%
Similar 10Y revenue/share CAGR to ADI's 61.23%. Walter Schloss might see both firms benefiting from the same long-term demand.
7.99%
5Y revenue/share CAGR under 50% of ADI's 17.03%. Michael Burry would suspect a significant competitive gap or product weakness.
6.84%
3Y revenue/share CAGR under 50% of ADI's 15.96%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
56.58%
10Y OCF/share CAGR under 50% of ADI's 132.80%. Michael Burry would worry about a persistent underperformance in cash creation.
70.44%
5Y OCF/share CAGR above 1.5x ADI's 17.74%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
33.92%
3Y OCF/share CAGR at 75-90% of ADI's 45.17%. Bill Ackman would press for improvements in margin or overhead to catch up.
75.01%
Net income/share CAGR at 50-75% of ADI's 107.01%. Martin Whitman might question if the firm’s product or cost base lags behind.
5.73%
Below 50% of ADI's 17.02%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
72.03%
3Y net income/share CAGR above 1.5x ADI's 20.19%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
40.58%
10Y equity/share CAGR at 50-75% of ADI's 58.38%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
22.21%
Below 50% of ADI's 63.61%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
0.82%
Below 50% of ADI's 20.59%. Michael Burry suspects a serious short-term disadvantage in building book value.
1263.46%
10Y dividend/share CAGR above 1.5x ADI's 565.20%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
181.31%
5Y dividend/share CAGR above 1.5x ADI's 99.74%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
100.13%
3Y dividend/share CAGR above 1.5x ADI's 33.19%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
2.87%
AR growth well above ADI's 1.53%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.22%
Inventory shrinking or stable vs. ADI's 7.42%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
1.07%
Asset growth well under 50% of ADI's 3.33%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-0.60%
We have a declining book value while ADI shows 2.83%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
5.30%
Debt growth far above ADI's 0.02%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-5.33%
Our R&D shrinks while ADI invests at 1.67%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
7.06%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.